← Back to all trials
Recruiting
NCT06798363
Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma
Conditions: Infantile Hemangioma
Sex: All
Ages: N/A – 1 Year
Healthy volunteers: No
Phase: PHASE2, PHASE3
Enrollment: 32
Sponsor: West China Hospital
Location: West China Hospital of Sichuan University Chengdu Sichuan
Summary
The main objective of this study was to determine the efficacy of different doses of propranolol in the treatment of ulcerattion infantile hemangioma (IH).
Eligibility Criteria
Inclusion Criteria:
1. all patients with ulcer IH;
2. children with ulcer IH treated with propranolol.
Exclusion Criteria:
1\) children with ulcer IH who received other therapeutic interventions were excluded; 2) Children whose families refused to participate in the study; 3) patients with contraindications to oral propranolol, such as allergy to propranolol, severe bradycardia and bronchial asthma; 4) children lost to follow-up during oral propranolol treatment; 5) children unable to oral propranolol or continue to oral propranolol due to other reasons.
\-
Source: ClinicalTrials.gov (NCT06798363). StuddyBuddy aggregates publicly available trial information.
